Make your money go further for just 25p per day

AIM IHT

Victoriana going cheap

Brighton Pier

An entertainment business covered here, with its roots in the Victorian era, has just reported encouraging results. The shares look good value, but possibly for good reason, as our update here reflects. Elsewhere, there was an encouraging contract win for a business with its eyes on the future. (Free to read)


Bioventix: tough comparator, but solid as always

Bioventix (AIM:BVXP), the developer of high-affinity monoclonal antibodies for applications in clinical diagnostics, announced interim results for the six-months to 31 December 2021.

Bioventix currently offers a portfolio of antibodies to customers for both commercial use and R&D purposes, for the diagnosis or monitoring of a broad range of conditions, including heart disease, cancer, fertility, thyroid function and drug abuse. It supplies antibody products and services…

Sign up and read the full article

Register to continue reading our content.

Get FREE access now

Already a member? Login


Previous article Next article

Have your say

Log in or register to view or add comments.

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on Bioventix PLC

Accounting shenanigans | Dividends | Contract wins

27/03/2023 · Company Insights

Results and updates covered here include news of encouraging contract wins as well as a big…


Upgrades and a horror show!

24/10/2022 · Company Insights

Results and updates from AIM covered here include plenty of positives – there is yet another…


More on Brighton Pier Group

Business is booming, but…..

04/05/2023 · Company Insights

News covered here include fabulous results from a company benefitting from a highly supportive market. While…


Beware the fairy tale of EBITDA

26/09/2022 · Company Insights

We have always questioned the appropriateness of companies using adjusted EBITDA as a credible performance measure,…


More on Cambridge Cognition

Cash generators | Contract wins | Competition

14/06/2023 · Company Insights

News covered here includes excellent results from an investment management business, whose model portfolio service continues…


A neuroscience company with exciting potential

03/05/2023 · Company Insights

This developer of digital solutions to assess brain health has announced encouraging results with a very positive…


More Company Insights

Poor safety controls | Challenge to AIM?

CVS Group: great results but…

21/09/2023 · CVS Group

Looking good | Hard to Judge | As flat as it gets

Sign-up to our free email updates

SIGN UP